GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.975517
Abstract: Growing cancer cells are addicted to glutamine. Glutamate dehydrogenase 1 (GLUD1) is one of key enzymes in glutamine metabolism and plays a critical role in the malignancy of diverse tumors. However, its role and molecular… read more here.
Keywords: inhibiting pi3k; pi3k akt; ccrcc; glud1 level ... See more keywords